Lixiana tablets 15mg, manufactured by Daiichi Sankyo, contain edoxaban tosilate hydrate, a Factor Xa inhibitor used to prevent stroke and systemic embolism in patients with nonvalvular atrial fibrillation, and to treat and prevent deep vein thrombosis and pulmonary embolism. The YJ code is 3339002F1020, and the standard is 15mg 1 tablet.
Lixiana tablets 15mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →
